<DOC>
	<DOCNO>NCT00872963</DOCNO>
	<brief_summary>Malaria one lead cause deaths child five year old . Despite antimalarial drug insecticide treat bed net , establish mean treatment protection , malaria still continue affect many child . A malaria vaccine would effective way reduce malaria infection community . RTS , S/AS01E lead malaria vaccine candidate develop child Africa . The investigator do study find vaccine effective reduce infection malaria child age 5-17 month live Kenya Tanzania . The follow original study 14-18 month . The extended follow propose continue another four year .</brief_summary>
	<brief_title>An Extended Follow RTS , S/AS01E Malaria Vaccine Trial</brief_title>
	<detailed_description>The RTS , S/AS01E candidate malaria vaccine develop routine immunization infant child live malaria-endemic area part Expanded Program Immunization ( EPI ) . 30 % efficacy clinical malaria 58 % efficacy severe malaria disease see related vaccine , RTS , S/AS02A , child age 1 4 year ( Malaria-026 ) Mozambique . The efficacy clinical malaria infection sustain beyond 18 month . The RTS , S/AS01 vaccine develop parallel RTS , S/AS02 vaccine , differ adjuvant formulation show immunogenic.The utility partially effective vaccination depend heavily overall effect malaria incidence childâ€Ÿs acquisition natural immunity . However , cohort vaccinate Phase II study already discontinue follow episode malaria , plan Phase III study run 30 month post vaccination . The propose extend follow expect run four year inform design Phase 4 study may prove critical inform public health policy vaccine license .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Enrollment vaccination RTS , S/AS01E clinical trial ( NCT00380393 ) Written oral , sign thumbprinted witness informed consent obtain parent ( ) /guardian ( ) child . Moving study area , follow impractical .</criteria>
	<gender>All</gender>
	<minimum_age>19 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>malaria vaccine</keyword>
	<keyword>RTS , S ,</keyword>
</DOC>